Glofitamab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and ≥2 Prior Therapies: Results From a Pivotal Phase II Expansion Study

被引：0
|
作者：
Dickinson, Michael [1 ,2 ]
Carlo-Stella, Carmelo [3 ,4 ]
Morschhauser, Franck [5 ,6 ]
Bachy, Emmanuel [7 ]
Corradini, Paolo [8 ,9 ]
Iacoboni, Gloria [10 ]
Khan, Cyrus [11 ]
Wrobel, Thomasz [12 ]
Offner, Fritz [13 ]
Trneny, Marek [14 ]
Wu, Shang-Ju [15 ]
Cartron, Guillaume [16 ]
Hertzberg, Mark [17 ,18 ]
Sureda, Anna [19 ]
Perez-Callejo, David [20 ]
Lundberg, Linda [20 ]
Relf, James [21 ]
Clark, Emma [21 ]
Humphrey, Kathryn [21 ]
Hutchings, Martin [22 ]
机构：
[1] Royal Melbourne Hosp, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
[3] Humanitas Univ, Milan, Italy
[4] IRCCS Humanitas Res Hosp, Milan, Italy
[5] Hop Claude Huriez, Lille, France
[6] CHU Lille, Lille, France
[7] Ctr Hosp Lyon Sud, Lyon, France
[8] Univ Milan, Milan, Italy
[9] IRCSS Ist Nazl Tumori, Fdn Ist Ricovero & Cura Carattere Sci, Milan, Italy
[10] Vall dHebron Univ Hosp, Barcelona, Spain
[11] Allegheny Hlth Network, Pittsburgh, PA USA
[12] Uniwersytet Med Wroclawiu, Wroclaw, Poland
[13] Univ Ziekenhuis Gent, Ghent, Belgium
[14] Charles Univ Hosp, Prague, Czech Republic
[15] Natl Taiwan Univ Hosp, Taipei, Taiwan
[16] CHU Montpellier, Montpellier, France
[17] Prince Wales Hosp, Sydney, NSW, Australia
[18] Univ New South Wales, Sydney, NSW, Australia
[19] Inst Catala Oncol Hosp, Barcelona, Spain
[20] F Hoffmann La Roche Ltd, Basel, Switzerland
[21] Roche Prod Ltd, Welwyn Garden City, Herts, England
[22] Rigshosp, Copenhagen, Denmark
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
ABCL; glofitamab; diffuse large B-cell lymphoma; bispecific antibody; relapsed/refractory; phase II;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ABCL-478
引用
收藏
页码：S435 / S435
页数：1
相关论文
共 50 条
  • [1] Glofitamab in Relapsed Refractory Diffuse Large B-Cell Lymphoma: Single Center Experience
    Yaman, Samet
    Candir, Burcu Aslan
    Bozan, Ersin
    Dal, Mehmet Sinan
    Altuntas, Fevzi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S445 - S445
  • [2] Subcutaneous Epcoritamab in Patients With Relapsed or Refractory Large B-Cell Lymphoma (EPCORE NHL-1): Pivotal Results from a Phase 2 Study
    Thieblemont, Catherine
    Phillips, Tycel
    Ghesquieres, Herve
    Cheah, Chan Y.
    Clausen, Michael Roost
    Cunningham, David
    Do, Young Rok
    Feldman, Tatyana
    Gasiorowski, Robin
    Jurczak, Wojciech
    Kim, Tae Min
    Lewis, David John
    van der Poel, Marjolein
    Poon, Michelle Limei
    Doerr, Thomas
    Kilavuz, Nurgul
    Chen, Menghui
    Sacchi, Mariana
    Elliott, Brian
    Hutchings, Martin
    Lugtenburg, Pieternella
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S379 - S379
  • [3] Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data
    Atesoglu, Elif Birtas
    Gulbas, Zafer
    Uzay, Ant
    Ozcan, Muhit
    Ozkalemkas, Fahir
    Dal, Mehmet Sinan
    Kalyon, Hakan
    Akay, Olga Meltem
    Deveci, Burak
    Bekoz, Huseyin
    Sevindik, Omur Gokmen
    Toptas, Tayfur
    Yilmaz, Fergun
    Koyun, Derya
    Alkis, Nihan
    Alacacioglu, Inci
    Sonmez, Mehmet
    Yavasoglu, Irfan
    Tombak, Anil
    Mehtap, Ozgur
    Kurnaz, Fatih
    Yuce, Orhan Kemal
    Karakus, Volkan
    Turgut, Mehmet
    Kurekci, Derya Deniz
    Ayer, Mesut
    Keklik, Muzaffer
    Buyuktas, Deram
    Ozbalak, Murat
    Ferhanoglu, Burhan
    HEMATOLOGICAL ONCOLOGY, 2023, 41 (04) : 663 - 673
  • [4] Combination of Atezolizumab and Tazemetostat in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results From a Phase Ib Study
    Palomba, Maria Lia
    Cartron, Guillaume
    Popplewell, Leslie
    Ribrag, Vincent
    Westin, Jason
    Huw, Ling-Yuh
    Agarwal, Shefali
    Shivhare, Mahesh
    Hong, Wan-Jen
    Raval, Aparna
    Chang, Alice C.
    Penuel, Elicia
    Morschhauser, Franck
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (07) : 504 - 512
  • [5] A Phase 2b Study of Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
    Kalakonda, Nagesh
    Cavallo, Federica
    Follows, George
    Goy, Andre
    Vermaat, Joost S. P.
    Casasnovas, Olivier
    Lavee, Orly
    Maerevoet, Marie
    Zijlstra, Josee
    Bakhshi, Sameer
    Bouabdallah, Reda
    Choquet, Sylvain
    Gurion, Ronit
    Hill, Brian
    Jaeger, Ulrich
    Sancho, Juan-Manuel
    Schuster, Michael
    Thieblemont, Catherine
    De la Cruz, Fatima
    Egyed, Miklos
    Mishra, Sourav
    Offner, Fritz
    Vassilakopoulos, Theodoros
    Warzocha, Krzysztof
    McCarthy, Daniel
    Ma, Xiwen
    Corona, Kelly
    Saint-Martin, Jean-Richard
    Joshi, Anita
    Shah, Jatin
    Van den Neste, Eric
    Canales, Miguel
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S248 - S249
  • [6] Combination of Lenalidomide and Rituximab in Elderly Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Phase 2 Trial
    Zinzani, Pier Luigi
    Pellegrini, Cinzia
    Gandolfi, Letizia
    Stefoni, Vittorio
    Quirini, Federica
    Derenzini, Enrico
    Broccoli, Alessandro
    Argnani, Lisa
    Pileri, Stefano
    Baccarani, Michele
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (06) : 462 - 466
  • [7] Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Look at the Approved and Emerging Therapies
    Sawalha, Yazeed
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (12):
  • [8] A prognostic nomogram constructed for relapsed or refractory diffuse large B-cell lymphoma patients
    Jiang, Shiyu
    Qin, Yan
    Liu, Peng
    Yang, Jianliang
    Yang, Sheng
    He, Xiaohui
    Zhou, Shengyu
    Gui, Lin
    Zhang, Changgong
    Zhou, Liqiang
    Sun, Yan
    Shi, Yuankai
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (02) : E11 - E16
  • [9] Combination of Atezolizumab and Obinutuzumab in Patients with Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: Results from a Phase 1b Study
    Palomba, M. Lia
    Till, Brian G.
    Park, Steven I.
    Morschhauser, Franck
    Cartron, Guillaume
    Marks, Reinhard
    Shivhare, Mahesh
    Hong, Wan-Jen
    Raval, Aparna
    Chang, Alice C.
    Penuel, Elicia
    Popplewell, Leslie L.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (07) : E443 - E451
  • [10] A phase II trial of AZD1152 in relapsed/refractory diffuse large B-cell lymphoma
    Collins, Graham P.
    Eyre, Toby A.
    Linton, Kim M.
    Radford, John
    Vallance, Grant D.
    Soilleux, Elizabeth
    Hatton, Chris
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 170 (06) : 886 - 890
12345